This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Alves Corrêa, S. A. Articles by Guerreiro da Silva, I. D. C. Search for Related Content PubMed PubMed Citation Articles by Alves Corrêa, S. A. Articles by Guerreiro da Silva, I. D. C. Social Bookmarking                         What's this?

Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil, silaac{at}biofis.epm.br

Samuel Marcos Ribeiro de Noronha

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil

Naiara Correa Nogueira-de-Souza

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil

Cristina Valleta de Carvalho

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil

Ana Maria Massad Costa

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil

José Juvenal Linhares

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil

Mariano Tamura Vieira Gomes

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil

Ismael Dale Cotrim Guerreiro da Silva

Molecular Gynaecology Laboratory, Department of Gynaecology, Federal University of São Paulo, Rua Pedro de Toledo, 781 — 4th Floor, São Paulo, 04039-032 SP, Brazil

Introduction.We evaluated the association between components of the renin-angiotensin system and the development of breast cancer in a case-control study by means of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) and angiotensin II type 1 (AT ₁)-receptor A1166C polymorphisms.

Methods. Genotyping was performed by PCR-RFLP (restriction fragment length polymorphism) or PCR (polymerase chain reaction) using genomic DNA extracted from buccal cells of subjects with (101 cases) or without (307 controls) breast cancer.

Results.The frequencies of genotypes for ACE were: DD, ID and II (in %: cases: 60; 20; 20; controls: 46; 37; 17; p=0.019, ²); and for AT₁receptor were:AA,AC and CC (in %: cases: 65; 30; 5; controls: 51; 44; 5; p=0.114, ²).The results suggested that the A1166C polymorphism was not associated with breast cancer risk. On the other hand, for the ACE (I/D), there seemed to be different risks for cancer between cases and controls.

Conclusions.The ID genotype was less frequently associated with the disease than were the DD or II; that is, women with the ID genotype were 3.1 times less likely to develop breast cancer than those with the other genotypes.The ID genotype might be protective against breast cancer and the ACE (I/D) polymorphism a possible target for developing genetic markers for breast cancer.

Key Words: angiotensin-converting enzyme • angiotensin II type 1 receptor • breast cancer • genotyping • polymorphisms

References

• Sayed-Tabatabaei FA, Oostra BA, Isaacs A., van Duijn CM, Witteman JCM.. ACE polymorphisms. Circ Res 2006;98:1123-33.[Abstract/Free Full Text]
• de Gasparo M., Catt KJ, Inagami T., Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-72.[Abstract/Free Full Text]
• Wolf G., Ziyadeh FN, Helmchen U., Zahner G., Schroeder R., Stahl RA ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. Am J Physiol 1995;268:F940-7.[Web of Science][Medline] [Order article via Infotrieve]
• Stoll M., Meffert S., Stroth U., Unger T. Growth or anti-growth: angiotensin and the endothelium. J Hypertens 1995;13:1529-34.[Web of Science][Medline] [Order article via Infotrieve]
• Tian Y., Balla T., Baukal AJ, Catt KJ Growth responses to angiotensin II in bovine adrenal glomerulosa cells. Am J Physiol 1995;268:E135-44.[Web of Science][Medline] [Order article via Infotrieve]
• Fujita M., Hayashi I., Yamashina S., Itoman M., Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002;294:441-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Muscella A., Greco S., Elia MG, Storelli C., Marsigliante S. Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol 2002;173:315-23.[Abstract]
• Nakajima M., Hutchinson HG, Fujinaga M. et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain of function study using in vivo gene transfer. Proc Natl Acad Sci U S A 1995;92:10663-7.[Abstract/Free Full Text]
• De Paepe B., Verstraeten VL, De Potter CR, Vakaet LA, Bullock GR Increased angiotensin II type-2 receptor density in hyperplasia. DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression. Histochem Cell Biol 2002;116:247-54.[Web of Science]
• Inwang ER, Puddefoot JR, Brown CL et al. Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer 1997;75:1279-83.[Web of Science][Medline] [Order article via Infotrieve]
• Marsigliante S., Resta L., Muscella A., Vinson GP, Marzullo A., Storelli C. AT1 angiotensin II receptor subtype in the human laryns and squamous laryngeal carcinoma. Cancer Lett 1996; 110(1-2):19-27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Takeda H., Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 2001;158:1633-7.[Abstract/Free Full Text]
• Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol F., Soubrier FJ An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Clin Invest 1990;86:1343-6.[CrossRef]
• Curnow KM, Pascoe L., White PC Genetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol 1992;6:1113-18.[Abstract/Free Full Text]
• Davies E., Bonnardeaux A., Lathrop GM, Corvol P., Clauser E., Soubrier F. Angiotensin II (type I) receptor locus: CA repeat polymorphism and genetic mapping. Hum Mol Genet 1994;3:83-4.
• Furuta H., Guo DF, Inagami T. Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem Biophys Res Commun 1992;183:8-13.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bonnardeaux A., Davies E., Jeunemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-9.[Abstract/Free Full Text]
• Castellano M., Muiesan ML, Beschi M. et al. Angiotensin II type 1 receptor A/C1166 polymorphism: relationships with blood pressure and cardiovascular structure. Hypertension 1996;28:1076-80.[Abstract/Free Full Text]
• Amant C., Hamon M., Bauters C. et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997; 29:486-90.[Abstract]
• Talamine R., Franceschi S., Favero A., Negri E., Parazzini F., La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997;75:1699-703.[Web of Science][Medline] [Order article via Infotrieve]
• Peeters PH, van Noord PA, Hoes AW, Fracheboud J., Gimbrere CH, Grobbee DE Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens 2000;18:249-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mack TM, Henderson BE, Gerkins VR, Arthur M., Baptista J., Pike MC Reserpine and breast cancer in a retirement community. N Engl J Med 1975;292:1366-71.[Abstract]
• Lever AF, Hole DJ, Gillis CR et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Meier CR, Derby LE, Jick SS, Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med 2000;160:349-53.[Abstract/Free Full Text]
• Koh WP, Yuan JM, Sun CL et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003;63:573-8.[Abstract/Free Full Text]
• Haiman CA, Henderson SO, Bretsky P., Kolonel LN, Henderson BE Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 2003;63:6984-7.[Abstract/Free Full Text]
• Freitas-Silva M., Pereira D., Coelho C., Bicho M., Lopes C., Medeiros R. Angiotensin I converting enzyme gene insertion/ deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 2004;155:42-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Correa SAA, Franca LP, Costa-Neto CM, Oliveira L., Paiva AC, Shimuta SI Relevant role of Leu265 in helix VI of the angiotensin AT1 receptor in agonist binding and activity. Can J Physiol Pharmacol 2002;80:426-30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Correa SAA, Zalcberg H., Han SW et al. Aliphatic amino acids in helix VI of the AT1 receptor play a relevant role in agonist binding and activity. Regul Pept 2002;106:33-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Correa SAA, Pacheco NAS, Costa-Neto CM et al. New mutants of angiotensin II AT1 receptor expressed in CHO cells caused morphological change and inhibition of cell growth. Regul Pept 2005;131:18-22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Koh WP, Yuan JM, Van Den Berg D., Lee HP, Yu MC Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005;26:459-64.[Abstract/Free Full Text]
• Szombathy T., Jánoskúti L., Szalai C. et al. Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome. Am Heart J 2000;139:101-5.[Web of Science][Medline] [Order article via Infotrieve]
• Fukazawa R., Sonobe T., Hamamoto K. et al. Possible synergic effect of angiotensin-I converting enzyme gene insertion/ deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 2004;56:597-601.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wang JG, Staessen JA Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 2000;410:289-302.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lee EJ Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 1994;37:212-14.[Web of Science][Medline] [Order article via Infotrieve]
• Morise T., Takeuchi Y., Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 1994;343:125.[Web of Science][Medline] [Order article via Infotrieve]
• Sanderson JE, Young RP, Yu CM, Chan S., Critchley JA, Woo KS Lack of association between insertion/deletion polymorphism of the angiotensin converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilate cardiomyopathy in the Chinese. Am J Cardiol 1996;77:1008-10. 38. Young RP, Thomas GN, Critchley JA, Tomlinson B., Woo KS, Sanderson JE Interethnic differences in coronary heart disease mortality in 25 populations: association with the angiotensin-converting enzyme DD genotype frequency. J Cardiovasc 1998;5:303-7.
• Méthot J., Hamelin BA, Arsenault M., Bogaty P., Plante S., Poirier P. The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women. Menopause 2006; 13:959-66.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 10, No. 1, 51-58 (2009)
DOI: 10.1177/1470320309102317


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Alves Corrêa, S. A. Articles by Guerreiro da Silva, I. D. C. Search for Related Content PubMed PubMed Citation Articles by Alves Corrêa, S. A. Articles by Guerreiro da Silva, I. D. C. Social Bookmarking                         What's this?